The global market value was USD 5.53 billion in 2023, driven by the increasing advancements in sequencing technologies across the globe. The market size is anticipated to grow at a CAGR of 16.0% during the forecast period of 2024-2032 to achieve a value of USD 21.32 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Researchers and developers have developed a variety of DNA sequencing technologies that provide higher precision and faster sequencing at a reduced cost. For example, Illumina, a key player, has introduced a device consisting of 10 ultra-throughput sequencers and can sequence approximately 18,000 human genomes per year. Researchers now use ground-breaking genome mapping techniques that take less time to complete. Thus, the reduction of sequencing costs has led many organisations to invest in research and development programs, providing economical approaches such as genome sequencing as a whole, novo sequencing, and the detection of particular diseases. These factors are expected to propel the growth of the DNA sequencing products market in the coming years.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
DNA sequencing is the method used to measure sequences correctly in a DNA molecule, i.e. cytosine, adenine, thymine, and guanine, of the four nuclear bases. It plays a significant role in the mapping of the human genome and helps in multiple applications of scientific science. The products, thus, are gaining popularity in the pharmaceutical industry by helping researchers understand complex diseases and, in effect, by creating customised patient medicines. DNA profiling has, furthermore, become an essential part of forensic science, since these profiles enable researchers to recognise and differentiate multiple samples from a DNA pool.
On the basis of product type, the industry can be divided into the following:
It finds wide applications in the following:
The end-use sectors in the market are:
The regional markets for the products include North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Microorganism genome mapping and sequencing have made it possible for farmers to use them for crops and food plants. Over the last few years, in food plants, different bacterial genes have been used to enhance their resistance to insects and pests, which has improved their production and nutritional value. Genomes from many domesticated animals, including chicken, pig, cow, sheep, and horses, were sequenced, partially or entirely, and were also shown to be useful for the development of animals with improved meat and milk quality. The role of DNA sequencing in the in-vitro diagnostics industry is expected to gain momentum, especially for point-of-care diagnostics. DNA sequencing allows the development of accurate medicine to provide patients with unique medications or therapies. This also offers numerous tools for genetic sequencing and study of DNA data with high precision and rapid diagnosis at the point of treatment. Thus, the growing adoption of the products across agricultural and medical sectors is expected to support the growth of the global DNA sequencing products market.
The report gives a detailed analysis of the following companies in the global DNA sequencing products market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
|Scope of the Report||
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Product Type||
|Breakup by Technology||
|Breakup by Applications||
|Breakup by End User||
|Breakup by Region||
|Report Price and Purchase Option||Explore our purchase options that are best suited to your resources and industry needs.|
|Delivery Format||Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global DNA Sequencing Products Market Overview
3.1 Global DNA Sequencing Products Market Historical Value (2017-2023)
3.2 Global DNA Sequencing Products Market Forecast Value (2024-2032)
4 Global DNA Sequencing Products Market Landscape
4.1 Global DNA Sequencing Products Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global DNA Sequencing Products Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Applications
4.2.3 Analysis by End User
5 Global DNA Sequencing Products Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global DNA Sequencing Products Market Segmentation
6.1 Global DNA Sequencing Products Market by Product Type
6.1.1 Market Overview
6.2 Global DNA Sequencing Products Market by Technology
6.2.1 Market Overview
6.2.2 Sanger Sequencing
6.2.3 Next-Generation Sequencing
188.8.131.52 Whole Genome Sequencing (WGS)
184.108.40.206 Whole Exome Sequencing (WES)
220.127.116.11 Targeted Sequencing & Resequencing
6.3 Global DNA Sequencing Products Market by Applications
6.3.1 Market Overview
6.3.4 Reproductive Health
6.3.6 Personalized Medicine
6.4 Global DNA Sequencing Products Market by End User
6.4.1 Market Overview
6.4.2 Academic Institutes and Research Centers
6.4.3 Hospitals and Clinics
6.4.4 Pharmaceutical and Biotechnology Companies
6.5 Global DNA Sequencing Products Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America DNA Sequencing Products Market
7.1 Market Share by Country
7.2 United States of America
8 Europe DNA Sequencing Products Market
8.1 Market Share by Country
8.2 United Kingdom
9 Asia Pacific DNA Sequencing Products Market
9.1 Market Share by Country
10 Latin America DNA Sequencing Products Market
10.1 Market Share by Country
11 Middle East and Africa DNA Sequencing Products Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.5 South Africa
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
17 Supplier Landscape
17.1 Illumina Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.2 Thermo Fischer Scientific Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.3 Oxford Nanopore Technologies plc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.4 Agilent Technologies, Inc.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.6 PerkinElmer Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.8 Eurofins Scientific
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.9 F. Hoffmann-La Roche Ltd.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.10 Takara Bio Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.11 GENEWIZ, Inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.12 Hamilton Company
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.13 Macrogen Inc.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.14 Zymo Research Corporation
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
18 Global DNA Sequencing Products Market - Distribution Model (Additional Insight)
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
*Additional insights provided are customisable as per client requirements.
Globally, DNA Sequencing Products market reached a value of USD 5.53 billion in 2023.
The market is projected to expand at a CAGR of 16.0% from 2023 to 2031, growing to USD 21.32 billion by 2032.
The major drivers of the industry, such as increasing use in the farming activities, rising demand for improved nutritional value, and growing technological advancements are expected to aid the market growth.
The key market trend guiding the growth of the DNA sequencing products market include the growing use of the product in the in-vitro diagnostics industry, along with increasing investments into R&D activities.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Consumables and reagents, and equipment are the major product types of DNA sequencing products in the industry.
Biomarkers, diagnostics, reproductive health, forensics, and personalised medicine, among others, are the significant applications of DNA sequencing products.
Academic and government research institutes, pharmaceutical and biotechnology companies, and hospitals and clinics, among others, are the major end-uses of the product.
The major players in the industry are Illumina Inc, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Pacific Biosciences of California, Inc., and Beckman Coulter, Inc., among others.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.